investorscraft@gmail.com

Intrinsic ValueSolbar Ningbo Protein Technology Co., Ltd. (603231.SS)

Previous Close$19.92
Intrinsic Value
Upside potential
Previous Close
$19.92

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Solbar Ningbo Protein Technology operates as a specialized manufacturer of soy protein products, serving both domestic Chinese and international markets. The company focuses on the research, development, production, and distribution of various soy-based protein solutions including functional concentrates, textured proteins, isolated proteins, and defatted soy flours. These products cater to the growing demand for plant-based protein alternatives in the food industry, positioning the company within the competitive packaged foods sector. Solbar employs a dual distribution strategy, utilizing both a network of distributors and direct sales channels to reach multinational customers, enabling broad market penetration. The company's foundation in 2003 and Ningbo headquarters provide strategic access to China's agricultural resources and export infrastructure. This established presence supports its role as a key supplier in the plant protein value chain, competing on quality and specialization rather than scale alone.

Revenue Profitability And Efficiency

The company generated CNY 1.56 billion in revenue with net income of CNY 121 million, achieving a net margin of approximately 7.8%. Operating cash flow of CNY 147.7 million demonstrates solid cash generation from core operations, though significant capital expenditures of CNY 168.5 million indicate ongoing investment in production capacity and technological capabilities.

Earnings Power And Capital Efficiency

Solbar delivered diluted EPS of CNY 0.63, reflecting reasonable earnings power relative to its market capitalization. The substantial capital expenditure program suggests focused investment in expanding production capabilities, which may enhance future earnings potential through increased capacity and improved operational efficiency in the growing plant-based protein market.

Balance Sheet And Financial Health

The company maintains a strong liquidity position with CNY 320 million in cash and equivalents against modest total debt of CNY 23.8 million, indicating minimal leverage and robust financial flexibility. This conservative capital structure provides stability and capacity for strategic investments or weathering market fluctuations in the competitive food ingredients sector.

Growth Trends And Dividend Policy

Solbar demonstrates a shareholder-friendly approach with a dividend per share of CNY 0.30, representing a payout ratio of approximately 48% based on current EPS. This balanced capital allocation strategy supports both investor returns and retained earnings for future growth initiatives in the expanding plant-based protein market.

Valuation And Market Expectations

With a market capitalization of CNY 2.49 billion, the company trades at approximately 20.6 times earnings and 1.6 times revenue. The beta of 1.32 indicates higher volatility than the broader market, reflecting investor perception of both growth potential and sector-specific risks in the competitive food ingredients industry.

Strategic Advantages And Outlook

The company benefits from its specialized focus on soy protein technology and established market position in China's growing plant-based food sector. Its technical expertise and diversified product portfolio provide competitive advantages, though success depends on maintaining innovation leadership and effectively navigating raw material cost fluctuations and intensifying market competition.

Sources

Company financial reportsStock exchange disclosuresMarket data providers

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount